$-0.06 EPS Expected for OraSure Technologies, Inc. (OSUR)

April 17, 2018 - By Peter Erickson

Investors sentiment decreased to 0.83 in Q4 2017. Its down 0.18, from 1.01 in 2017Q3. It dropped, as 45 investors sold OraSure Technologies, Inc. shares while 56 reduced holdings. 34 funds opened positions while 50 raised stakes. 53.79 million shares or 2.08% less from 54.93 million shares in 2017Q3 were reported.
Sei Invests owns 0% invested in OraSure Technologies, Inc. (NASDAQ:OSUR) for 6,810 shares. D E Shaw And holds 0.01% of its portfolio in OraSure Technologies, Inc. (NASDAQ:OSUR) for 358,780 shares. Alps Advsrs accumulated 21,720 shares or 0% of the stock. Ameriprise Fincl Inc, a Minnesota-based fund reported 581,981 shares. International Gru Inc holds 45,488 shares or 0% of its portfolio. California State Teachers Retirement holds 0% or 89,217 shares. Texas Permanent School Fund reported 40,996 shares or 0.01% of all its holdings. State Board Of Administration Of Florida Retirement invested in 0% or 47,458 shares. Zurcher Kantonalbank (Zurich Cantonalbank) invested in 5,283 shares. Barclays Public Ltd Co has 0% invested in OraSure Technologies, Inc. (NASDAQ:OSUR) for 15,843 shares. Moreover, Proshare Advisors Ltd Limited Liability Company has 0% invested in OraSure Technologies, Inc. (NASDAQ:OSUR). First Tru Advisors Ltd Partnership invested 0.01% of its portfolio in OraSure Technologies, Inc. (NASDAQ:OSUR). 162,140 are owned by Deutsche Bancorp Ag. Legal General Public Ltd Com has invested 0% of its portfolio in OraSure Technologies, Inc. (NASDAQ:OSUR). Parkside Bancorp Tru holds 0% or 24 shares.

Since February 15, 2018, it had 0 insider purchases, and 2 sales for $778,707 activity. The insider TANG STEPHEN S PHD sold $419,247.

Analysts expect OraSure Technologies, Inc. (NASDAQ:OSUR) to report $-0.06 EPS on May, 2.They anticipate $0.27 EPS change or 128.57 % from last quarter’s $0.21 EPS. After having $0.12 EPS previously, OraSure Technologies, Inc.’s analysts see -150.00 % EPS growth. The stock increased 1.68% or $0.29 during the last trading session, reaching $17.59. About 219,959 shares traded. OraSure Technologies, Inc. (NASDAQ:OSUR) has risen 34.91% since April 17, 2017 and is uptrending. It has outperformed by 23.36% the S&P500.

OraSure Technologies, Inc. (NASDAQ:OSUR) Ratings Coverage

Among 3 analysts covering Orasure Technologies (NASDAQ:OSUR), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Orasure Technologies had 8 analyst reports since October 20, 2017 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, November 2 by Canaccord Genuity. The company was maintained on Tuesday, February 13 by Jefferies. The firm has “Buy” rating by Jefferies given on Friday, October 20. Canaccord Genuity maintained the stock with “Buy” rating in Monday, October 23 report. The stock has “Hold” rating by Jefferies on Thursday, November 2. The firm has “Buy” rating by Canaccord Genuity given on Friday, February 2. The rating was maintained by Canaccord Genuity on Wednesday, November 22 with “Buy”.

OraSure Technologies, Inc., together with its subsidiaries, develops, makes, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company has market cap of $1.08 billion. It operates in two divisions, OSUR and DNAG. It has a 34.49 P/E ratio. The firm also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests.

OraSure Technologies, Inc. (NASDAQ:OSUR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.